Jun 08, 2017 11:00 am UTC| Business
BOULDER, Colo., June 08, 2017 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that interim...
Mammoth Energy Services, Inc. Announces Multi-Year Take-Or-Pay Sand Contract
Jun 08, 2017 11:00 am UTC| Business
OKLAHOMA CITY, Okla., June 08, 2017 -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ:TUSK) announced that it has entered into a multi-year take-or-pay sand contract with a leading third-party...
Plug Power Confirms Details for Its Annual Shareholder Meeting on June 28, 2017
Jun 08, 2017 11:00 am UTC| Business
LATHAM, N.Y., June 08, 2017 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, has confirmed access and webcast details for its 2017 annual shareholder meeting....
VBL Therapeutics Awarded $2.5 Million Grant by the Israel Innovation Authority
Jun 08, 2017 11:00 am UTC| Business
TEL AVIV, Israel, June 08, 2017 -- VBL Therapeutics (Nasdaq:VBLT) today announced that it has been awarded a grant of 8.75 million New Israeli Shekels (approximately $2.5 million) by the Israel Innovation Authority. The...
3D Signatures Advances Hodgkin’s Lymphoma Test
Jun 08, 2017 11:00 am UTC| Business
TORONTO, June 08, 2017 -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), is pleased to announce that the clinical trial component (the “Clinical Trial”) of its Hodgkin’s lymphoma (“HL”)...
NewLink Genetics to Regain Rights to GDC-0919
Jun 08, 2017 11:00 am UTC| Business
AMES, Iowa, June 08, 2017 -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that on June 6, 2017, Genentech, a member of the Roche Group, informed NewLink Genetics that it intends to return the rights to IDO...
Jun 08, 2017 11:00 am UTC| Business
SAN DIEGO, June 08, 2017 -- Cytori Therapeutics, Inc.(NASDAQ:CYTX) (“Cytori” or the “Company”) today announced the publication of long-term follow-up data reporting patient satisfaction and surveillance for cancer...